COVID-19 Therapeutics for Nonhospitalized Patients

JAMA. 2022 Feb 15;327(7):617-618. doi: 10.1001/jama.2022.0335.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / therapeutic use
  • Alanine / analogs & derivatives
  • Alanine / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antibodies, Neutralizing / therapeutic use
  • Antiviral Agents / therapeutic use*
  • COVID-19 Drug Treatment*
  • Child
  • Cytidine / analogs & derivatives
  • Cytidine / therapeutic use
  • Drug Combinations
  • Female
  • Health Care Rationing
  • Humans
  • Hydroxylamines / therapeutic use
  • Lactams / therapeutic use
  • Leucine / therapeutic use
  • Nitriles / therapeutic use
  • Outpatients
  • Pregnancy
  • Proline / therapeutic use
  • Ritonavir / therapeutic use

Substances

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neutralizing
  • Antiviral Agents
  • Drug Combinations
  • Hydroxylamines
  • Lactams
  • Nitriles
  • nirmatrelvir and ritonavir drug combination
  • sotrovimab
  • remdesivir
  • Adenosine Monophosphate
  • Cytidine
  • Proline
  • Leucine
  • Ritonavir
  • Alanine
  • molnupiravir